Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in Complex Regional Pain Syndrome Type 1
NCT00109772Phase 2Terminated
- Sponsor
- Celgene Corporation
- Start
- Feb 2005
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in Complex Regional Pain Syndrome Type 1 (CRPS-1), sponsored by Celgene Corporation. Started Feb 2005; status: terminated.
02
Drugs
lenalidomide
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on NCT00109772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109772.